{
    "clinical_study": {
        "@rank": "55357", 
        "arm_group": [
            {
                "arm_group_label": "Primary Breast Tumor", 
                "description": "Immunohistochemical staining of paraffin embedded tissue blocks of primary breast tumor for estrogen and progesterone receptors was performed."
            }, 
            {
                "arm_group_label": "Axillary Lymph Nodes.", 
                "description": "Immunohistochemical staining of paraffin embedded tissue blocks of axillary lymph nodes for estrogen and progesterone receptors was performed."
            }
        ], 
        "biospec_descr": {
            "textblock": "Paraffin embedded tissue blocks of primary breast tumor and axillary lymph nodes."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine discordant hormonal status of primary breast tumor\n      and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer\n      patients."
        }, 
        "brief_title": "Discordant Hormonal Status of Breast Cancer.", 
        "completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "condition": "Malignant Neoplasm of Breast.", 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Hormonal status between primary breast tumor and axillary lymph node were analyzed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Breast cancer patients stage I,II and III with axillary lymph nodes metastasis.\n\n        Exclusion Criteria:\n\n          -  Breast cancer patients stage I,II and III without axillary lymph nodes metastasis."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "25 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Breast Cancer Patients Stage I,II and III."
            }
        }, 
        "enrollment": {
            "#text": "105", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943032", 
            "org_study_id": "EC 196/2010"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 19, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ratchathewi", 
                    "country": "Thailand", 
                    "state": "Bangkok", 
                    "zip": "10400"
                }, 
                "name": "National Cancer Institute, Thailand."
            }
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_groups": "2", 
        "official_title": "Discordant Hormonal Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.", 
        "overall_official": {
            "affiliation": "National Cancer Institute, Thailand", 
            "last_name": "AKANIST PIYAPANT, MD.,FRCST.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Thailand: Ministry of Public Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Association of estrogen and progesterone status between primary breast tumor and axillary lymph nodes was analyzed by using the \u03c72 test", 
            "measure": "Association of hormonal status between primary breast tumor and axillary lymph nodes", 
            "safety_issue": "No", 
            "time_frame": "Up to 1 year"
        }, 
        "reference": [
            {
                "PMID": "15317891", 
                "citation": "Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004 Aug 19;351(8):781-91."
            }, 
            {
                "PMID": "19914540", 
                "citation": "Cristofanilli M. The biological information obtainable from circulating tumor cells. Breast. 2009 Oct;18 Suppl 3:S38-40. doi: 10.1016/S0960-9776(09)70270-X."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943032"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Cancer Institute, Thailand", 
            "investigator_full_name": "AKANIST  PIYAPANT, MD.,FRCST.", 
            "investigator_title": "MD.,FRCST. Surgical Oncologist.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "National Cancer Institute, Thailand", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute, Thailand", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Year", 
        "verification_date": "September 2013"
    }
}